News zum Sektor Gesundheit aus Asien

 

ExxonMobil, Eli Lilly, Johnson & Johnson, and Sinopec headline a two-day program where petrochemicals, pharma, and the energy transition converge HOUSTON, June 3, 2026 /PRNewswire/ -- ChemE Show 2026 Powered by ACHEMA opens June 9-10 at the George R. Brown Convention Center in Houston,......

The Danaher company expands its collaboration with AstraZeneca and Daiichi Sankyo to develop an end-to-end system for TROP2 NMR in non-small cell lung cancer NEWCASTLE, United Kingdom, June 3, 2026 /PRNewswire/ -- Leica Biosystems, a Danaher company and a global leader in end-to-end......

Citi published a research report noting that bipartisan US lawmakers proposed a bill on June 2 to include US outbound investment in Chinas biotechnology sector under the review requirements of the Comprehensive Outbound Investment National Security Act (COINS Act). The proposed legislation, titled the National Security Biotechno......

GenScript Biotech Holdings surged in Hong Kong after the Chinese biotechnology company pushed back against renewed scrutiny from US lawmakers over alleged national security concerns. The shares rose as much as 29 per cent on Wednesday before trimming gains to trade 18 per cent higher at HK$14.35 by late morning. The benchmark Hang Seng Index fell 1.6 per cent. The Nanjing-based company issued a statement saying it operated transparently and professionally across all markets and adhered to the......

SHANGHAI and HONG KONG, June 3, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for......

InnoCare's novel BCL2i mesutoclax in MDS and AML was released at 2026 ASCO as an oral presentation, demonstrating outstanding efficacy and safety....

SHANGHAI, June 2, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has been named to the CDP Supplier Engagement Assessment (SEA) A List for the second consecutive year. The......

GENSCRIPT BIO (01548.HK) opened 14.99% higher today and once reached a peak of HKD15.6. It last stood at HKD14.48, up 19.28%, with a turnover of 29.861 million shares, involving HKD437 million.Legend Biotech Corporation (LEGN.US), an associate of the Company, announced that promising preliminary clinical data for LB2501, its inv......

Um den gesamten Artikel unter aastocks.com zu lesen, klicken Sie bitte auf die Überschrift...

CSPC PHARMA (01093.HK) announced that its subsidiary, CSPC Megalith Biopharmaceutical Co., Ltd., presented Phase I clinical data of SYS6043 in an oral presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.The study is a multicenter, open-label, single-arm Phase I/II clinical trial (ChiCTR2400094683......

CSPC PHARMA (01093.HK) announced that its first mRNA-LNP-based dual-target chimeric antigen receptor T-cell injection (SYS6063 injection) developed by the group has been approved by the National Medical Products Administration of China to conduct clinical trials in China.The approved clinical indication is relapsed and refractor......

WALTHAM, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in June:...

Joby Aviation, Curaleaf Holdings, and Pony AI may not be the safest stocks to own, but they possess some attractive upside in the future....

– 87% ORR and 70% CRc in venetoclax-naïve and 48% ORR and 24% CRc in venetoclax-experienced patients at the recommended 600 mg once-daily dose –...

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

There was HKD950.8 million, HKD344.4 million and HKD32 million Southbound Trading net inflow to SMIC (00981.HK), AKESO (09926.HK) and BABA-W (09988.HK).There was HKD2.1 billion, HKD916.6 million and HKD716.4 million Southbound Trading net outflow from TENCENT (00700.HK), XIAOMI-W (01810.HK) and MEITUAN-W (03690.HK).For Southboun......

WUXI APPTEC (02359.HK) repurchased 1.0324 million ordinary shares of the company on the Stock Exchange of Hong Kong today (2nd) at prices ranging from HKD122.6 to HKD130.2 per share, involving approximately HKD155 million.Since the approval of the share repurchase mandate on 28 April 2026, the company has cumulatively repurchase......

China SXT Pharmaceuticals shares rose 25.6% after hours after announcing an ATM equity offering of up to $100 million via Univest Securities. Importance Rank:  1 read more...

BofAS issued a report stating that AKESO (09926.HK) presented the overall survival analysis of the HARMONi-6 study at the oral Plenary Session of ASCO 2026. This marks the first time in ASCOs 61-year history that an innovative oncology drug originally developed in China has been selected for the Plenary Session.Given the strong ......

LIVZON PHARMA (01513.HK) announced that its controlling subsidiary Livzon Mabpharm has received a "Notice of Acceptance" issued by the National Medical Products Administration. The domestic production drug registration and marketing authorization application for "Laikang Qita Monoclonal Antibody Injection", jointly developed by ......